3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
2
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Multiple Myeloma
363
Precursor Cell Lymphoblastic Leukemia-Lymphoma
89
Leukemia
61
Neoplasms, Plasma Cell
60
Lymphoma
59
Recurrence
52
Neoplasms
34
Vomiting
33
Lymphoma, Non-Hodgkin
32
Immunoglobulin Light-chain Amyloidosis
27
Lymphoma, Mantle-Cell
26
Burkitt Lymphoma
26
Nausea
22
Lymphoma, Large B-Cell, Diffuse
21
Leukemia, Lymphocytic, Chronic, B-Cell
21
Waldenstrom Macroglobulinemia
19
Prostatic Neoplasms
19
Lymphoma, Follicular
18
Hodgkin Disease
18
Neoplasm Metastasis
14
Breast Neoplasms
14
Amyloidosis
12
Lymphoma, B-Cell, Marginal Zone
11
Leukemia, Myeloid, Acute
11
Carcinoma, Non-Small-Cell Lung
11
Ovarian Neoplasms
9
Lymphoma, Large-Cell, Immunoblastic
9
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Lymphoma, T-Cell, Cutaneous
8
Colonic Neoplasms
8
Interventions
Rituximab
4
Valganciclovir
2
Valacyclovir
2
Carboplatin
2
Acyclovir
2
valomaciclovir
1
threonic acid
1
otelixizumab
1
cc-486
1
Zidovudine
1
Vincristine
1
Vaccines
1
Tomography, X-Ray Computed
1
Prednisone
1
Polymerase Chain Reaction
1
Methotrexate
1
Matrix-M
1
Magnesium Sulfate
1
MVA vaccine
1
Leucovorin
1
Kidney Transplantation
1
Interferons
1
In Situ Hybridization
1
Immunohistochemistry
1
Granulocyte Colony-Stimulating Factor
1
Gene-Eden-VIR
1
Gastrectomy
1
Flow Cytometry
1
Filgrastim
1
Etoposide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Epstein-Barr Virus Infections
×
Dexamethasone
×
Clear all
NCT00953420
2017-08-18
CADEN
Baylor College of Medicine
Phase 2
Completed
20 enrolled